News and Announcements
MedAdvisor International Pty Ltd (ASX:MDR) Annual Update 2015; Lists on the ASX & Establishes Important Partnerships
- Published January 05, 2016 2:53PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
2015 Highlights:
- Raises $5m in oversubscribed public offer
- Commences trading on the ASX under ticker code MDR
- Announces new medication training relationship with Amgen
- Share price up 90% since listing
- Established important partnerships with pharmaceutical companies GSK, UCB, AstraZeneca and Apotex, as well as private health insurer, BUPA
- One quarter of Australian pharmacies subscribed to the MedAdvisor platform
MedAdvisor International Pty Ltd is an Australian medical technology business focused on designing and commercialising world class software platforms for medication management on mobile and internet devices. MedAdvisor’s Platform connects to pharmacy dispensing systems, automatically retrieving medication records and driving an intelligent training, information and reminder system to ensure correct and reliable medication use.
MedAdvisor has established strategic partnerships with Bupa Australia and most recently, distribution partner Apotex Australia. The company is also supported by Australia’s major pharmacies including Amcal, Chemmart, Terry White Chemists, Guardian Pharmacy and more.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
